Researchers Information System

日本語に切り替えるswitch to english

Ueno, Hideki

Graduate School of Medicine, Medicine Professor

Ueno, Hideki
list
    Last Updated :2024/06/07

    Basic Information

    Faculty

    • 医学部

    Academic Degree

    • 博士(医学)(京都大学)
    list
      Last Updated :2024/06/07

      Education

      Teaching subject(s)

      • From 01 Apr. 2024, To 31 Mar. 2025
        Immunology
        B013, Spring, Faculty of Medicine, 2
      • From 01 Apr. 2024, To 31 Mar. 2025
        Immunology
        E009, Spring, Graduate School of Medicine, 4
      • From 01 Apr. 2023, To 31 Mar. 2024
        Immunology
        B013, Spring, Faculty of Medicine, 2
      • From 01 Apr. 2023, To 31 Mar. 2024
        Immunology
        E009, Spring, Graduate School of Medicine, 4
      • From 01 Apr. 2022, To 31 Mar. 2023
        Immunology
        E009, Spring, Graduate School of Medicine, 4
      • From 01 Apr. 2022, To 31 Mar. 2023
        Immunology
        B013, Spring, Faculty of Medicine, 2
      • From 01 Apr. 2022, To 31 Mar. 2023
        Immunology
        L110, Spring, Faculty of Medicine, 0
      • From Apr. 2020, To Mar. 2021
        Immunology
        Spring, 医学部
      • From Apr. 2020, To Mar. 2021
        Immunology
        Spring, 医学部
      • From Apr. 2020, To Mar. 2021
        Immunology
        Spring, 医学研究科
      • From Apr. 2021, To Mar. 2022
        Immunology
        Spring, 医学部
      • From Apr. 2021, To Mar. 2022
        Immunology
        Spring, 医学部
      • From Apr. 2021, To Mar. 2022
        Immunology
        Spring, 医学研究科

      Participation in PhD Defense

      • Anti-integrin αvβ6 autoantibodies in patients with primary sclerosing cholangitis
        YOSHIDA HIROYUKI, Graduate School of Medicine, Chief Examiner
        25 Mar. 2024
      • THBS1-producing tumor-infiltrating monocyte-like cells contribute to immunosuppression and metastasis in colorectal cancer
        OMATSU MAYUKI, Graduate School of Medicine, Sub-chief Examiner
        25 Mar. 2024
      • M2-like tumor-associated macrophages promote epithelial?mesenchymal transition through the transforming growth factor β/Smad/zinc finger e-box binding homeobox pathway with increased metastatic potential and tumor cell proliferation in lung squamous cell carcinoma
        SUMITOMO RYOTA, Graduate School of Medicine, Sub-chief Examiner
        25 Mar. 2024
      • Rheumatoid factor recognizes specific domains of the IgG heavy chain complexed with HLA class II molecules
        ZHANG SHANSHAN, Graduate School of Medicine, Sub-chief Examiner
        23 Jan. 2024
      • Pathogenicity of IgG-Fc desialylation and its association with Th17 cells in an animal model of systemic lupus erythematosus
        NISHIDA YURI, Graduate School of Medicine, Chief Examiner
        23 Jan. 2024
      • Tertiary Lymphoid Tissues Are Microenvironments with Intensive Interactions between Immune Cells and Proinflammatory Parenchymal Cells in Aged Kidneys
        YOSHIKAWA TAKAHISA, Graduate School of Medicine, Sub-chief Examiner
        23 Jan. 2024
      • Humanized mouse models with endogenously developed human natural killer cells for in vivo immunogenicity testing of HLA class I-edited iPSC-derived cells
        FLAHOU Charlotte Astrid Denise, Graduate School of Medicine, Sub-chief Examiner
        25 Sep. 2023
      • Identification of anti-citrullinated osteopontin antibodies and increased inflammatory response by enhancement of osteopontin binding to fibroblast-like synoviocytes in rheumatoid arthritis
        UMEMOTO AKIO, Graduate School of Medicine, Sub-chief Examiner
        24 Jul. 2023
      • Necessity of HuR/ELAVL1 for activation-induced cytidine deaminase-dependent decrease in topoisomerase 1 in antibody diversification
        WAJID AMIN, Graduate School of Medicine, Sub-chief Examiner
        24 Jul. 2023
      • HNRNPU Facilitates Antibody Class Switch Recombination through C-NHEJ Promotion and R-loop Suppression
        AHMED MOHAMED REFAAT MOHAMED, Graduate School of Medicine, Sub-chief Examiner
        23 May 2023
      • Differential involvement of LUBAC-mediated linear ubiquitination in intestinal epithelial cells and macrophages during intestinal inflammation
        SAKAMOTO YUSUKE, Graduate School of Medicine, Sub-chief Examiner
        23 May 2023
      • Identification of T cell receptors targeting a neoantigen derived from recurrently mutated FGFR3
        TATE TOMOHIRO, Graduate School of Medicine, Sub-chief Examiner
        23 May 2023
      • Spermidine activates mitochondrial trifunctional protein and improves antitumor immunity in mice
        Muna Mohamed Ahmed Al-Habsi, Graduate School of Medicine, Sub-chief Examiner
        23 Mar. 2023
      • Retinoic acid receptor activity is required for the maintenance of type 1 innate lymphoid cells
        ASAHI TAKUMA, Graduate School of Medicine, Sub-chief Examiner
        23 Mar. 2023
      • The EZH2 inhibitor tazemetostat upregulates the expression of CCL17/TARC in B-cell lymphoma and enhances T-cell recruitment
        YUAN HEPEI, Graduate School of Medicine, Sub-chief Examiner
        23 Mar. 2023
      • Intracellular Group A Streptococcus Induces Golgi Fragmentation To Impair Host Defenses through Streptolysin O and NAD-Glycohydrolase
        IIBUSHI JUNPEI, Graduate School of Medicine, Sub-chief Examiner
        23 Mar. 2023
      • Improved anti-solid tumor response by humanized anti-podoplanin chimeric antigen receptor transduced human cytotoxic T cells in animal model
        ISHIKAWA AKIHIRO, Graduate School of Medicine, Sub-chief Examiner
        23 Mar. 2023
      • Rapid Flow Cytometry-Based Assay for the Functional Classification of MEFV Variants
        MAEDA YUKAKO, Graduate School of Medicine, Sub-chief Examiner
        23 Mar. 2023
      • PPARγ Agonist Attenuates Vocal Fold Fibrosis in Rats via Regulation of Macrophage Activation
        KABA SHINJI, Graduate School of Medicine, Chief Examiner
        25 Jul. 2022
      • In situ vaccination using unique TLR9 ligand K3-SPG induces long-lasting systemic immune response and synergizes with systemic and local immunotherapy
        OKADA HIROKAZU, Graduate School of Medicine, Sub-chief Examiner
        25 Jul. 2022
      • Immunosuppressive tumor microenvironment in Uterine Serous Carcinoma via CCL7 signal with myeloid-derived suppressor cells
        MISE YUKA, Graduate School of Medicine, Sub-chief Examiner
        24 Nov. 2022
      • The therapeutic potential of multiclonal tumoricidal T cells derived from tumor infiltrating lymphocyte-derived iPS cells
        ITO TAKESHI, Graduate School of Medicine, Sub-chief Examiner
        26 Jul. 2021
      • STAT5 interferes with PD-1 transcriptional activation and affects CD8+ T cell sensitivity to PD-1-dependent immunoregulation
        WANG GUANNING, Graduate School of Medicine, Sub-chief Examiner
        24 Jan. 2022
      • Cutaneous T-cell-attracting chemokine as a novel biomarker for predicting prognosis of idiopathic pulmonary fibrosis: a prospective observational study
        NIWAMOTO TAKAFUMI, Graduate School of Medicine, Sub-chief Examiner
        23 Mar. 2022
      • Increased expression of programmed cell death ligand 1 and galectin 9 in transplant recipients who achieved tolerance after immunosuppression withdrawal
        NGUYEN HAI NAM, Graduate School of Medicine, Sub-chief Examiner
        23 Mar. 2022
      • Targeted epigenetic induction of mitochondrial biogenesis enhances antitumor immunity in mouse model
        MADHU MALINEE, Graduate School of Medicine, Chief Examiner
        24 Jan. 2022
      • Identification of an Anti-Integrin αvβ6 Autoantibody in Patients With Ulcerative Colitis
        KUWADA TAKESHI, Graduate School of Medicine, Sub-chief Examiner
        23 Mar. 2022
      • Generation of hypoimmunogenic T cells from genetically engineered allogeneic iPS cells for off-the-shelf cancer immunotherapy
        BO WANG, Graduate School of Medicine, Sub-chief Examiner
        24 May 2021
      • Prolonged high-intensity exercise induces fluctuating immune responses to herpes simplex virus infection via glucocorticoids
        ADACHI AKIMASA, Graduate School of Medicine, Sub-chief Examiner
        24 Sep. 2021
      list
        Last Updated :2024/06/07

        Administration

        School management (title, position)

        • From 01 Apr. 2024, To 31 Mar. 2025
          大学院教育支援機構 大学院共通・横断教育企画評価専門委員会 英語部会
        • From 01 Apr. 2024, To 31 Mar. 2025
          国際高等教育院 企画評価専門委員会 英語部会
        • From 01 Apr. 2023, To 31 Mar. 2024
          大学院教育支援機構 大学院共通・横断教育企画評価専門委員会 英語部会 委員
        • From 01 Apr. 2023, To 31 Mar. 2024
          国際高等教育院 企画評価専門委員会 英語部会 委員
        • From 01 Apr. 2022, To 31 Mar. 2023
          大学院教育支援機構 大学院共通・横断教育企画評価専門委員会 英語部会 委員
        • From 01 Apr. 2022, To 31 Mar. 2023
          国際高等教育院 企画評価専門委員会 英語部会 委員

        Faculty management (title, position)

        • From 01 Oct. 2023, To 30 Sep. 2025
          大学評価部局委員会_委員
        • From 01 Oct. 2022, To 30 Sep. 2024
          管理体制委員会委員
        • From 01 Apr. 2023, To 31 Mar. 2025
          医学図書館運営委員会委員
        • From 01 Nov. 2022, To 31 Oct. 2024
          医学研究科期限付特定教員採用審査委員会委員

        ページ上部へ戻る